Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11376555 | 0.75 | NPSR1 (0.41) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL3664780 | 0.71 | NPSR1 (0.46) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL4732140 | 0.70 | NPSR1 (0.44) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL483415 | 0.70 | NPSR1 (0.44) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL8754925 | 0.66 | ALDH1A1 (0.51) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL15611386 | 0.65 | NPSR1 (0.40) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL25376834 | 0.65 | ALOX5 (0.39) | NPSR1ALDH1A1KMT2AGLATSHR | |
| SCHEMBL22170060 | 0.63 | ALDH1A1 (0.65) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL1018865 | 0.63 | ALDH1A1 (0.44) | NPSR1ALDH1A1NPC1KMT2AHTT | |
| SCHEMBL6375630 | 0.63 | NPSR1 (0.46) | NPSR1ALDH1A1NPC1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113301802-B | Synergistic preservative compositions, methods of making and methods of use thereof | ISP投资有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-107613767-B | Synergistic preservative composition | ISP投资有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-107613954-B | Synergistic compositions of dehydroacetic acid and methods of reducing yellowing in various end-use compositions | ISP投资有限公司 | 2021-10-19 | — | — | CN | claimed |
| CN-113301802-A | Synergistic preservative compositions, methods of making and methods of using the same | ISP投资有限公司 | 2021-08-24 | — | — | CN | claimed |
| EP-2538781-B1 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | CLARIANT SA (BR) | 2016-08-03 | — | — | EP | claimed |
| US-20160183520-A1 | Process For The Co-Encapsulation Of Biocidally Active Compounds In Clay Minerals Functionalized By Nitrogen Compounds | CLARIANT S.A. (BR) | 2016-06-30 | — | — | US | claimed |
| US-9228121-B2 | Process for the co-encapsulation of biocidally active compounds in clay minerals functionalized by nitrogen compounds | CLARIANT S.A. (BR) | 2016-01-05 | — | — | US | claimed |
| EP-2538781-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | Clariant S.A., Brazil (BR) | 2013-01-02 | — | — | EP | claimed |
| US-20120316259-A1 | Process For The Co-Encapsulation Of Biocidally Active Compounds In Clay Minerals Functionalized By Nitrogen Compounds | CLARIANT S.A. BRAZIL (BR) | 2012-12-13 | — | — | US | claimed |
| US-20120071522-A1 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES | ISP INVESTMENTS INC. (US) | 2012-03-22 | — | — | US | claimed |
| WO-2011103969-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | CLARIANT S. A. BRAZIL (BR) | 2011-09-01 | — | — | WO | claimed |
| WO-2006019517-A2 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES | ISP INVESTMENTS INC. (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060013833-A1 | Thermal stabilization of biocides in matrix compositions processed at elevated temperatures | ISP INVESTMENTS INC. | 2006-01-19 | — | — | US | claimed |
| CN-113301802-B | Synergistic preservative compositions, methods of making and methods of use thereof | ISP投资有限公司 | 2023-08-25 | — | — | CN | disclosed |
| EP-3528626-B1 | USE OF SURFACE-REACTED CALCIUM CARBONATE FOR PREPARING SUPERSATURATED AQUEOUS SYSTEMS | OMYA INT AG (CH) | 2022-08-31 | — | — | EP | disclosed |
| CN-107613767-B | Synergistic preservative composition | ISP投资有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20120071522-A1 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES | ISP INVESTMENTS INC. (US) | 2012-03-22 | — | — | US | disclosed |
| WO-2011103969-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | CLARIANT S. A. BRAZIL (BR) | 2011-09-01 | — | — | WO | disclosed |
| WO-2006019517-A2 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES | ISP INVESTMENTS INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20060013833-A1 | Thermal stabilization of biocides in matrix compositions processed at elevated temperatures | ISP INVESTMENTS INC. | 2006-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160183520-A1 | Process For The Co-Encapsulation Of Biocidally Active Compounds In Clay Minerals Functionalized By Nitrogen Compounds | SUV39H1, SUV39H2, TST | NPSR1 2449/4885ALDH1A1 4167/4885NPC1 1944/4885 |
| US-20120316259-A1 | Process For The Co-Encapsulation Of Biocidally Active Compounds In Clay Minerals Functionalized By Nitrogen Compounds | SUV39H1, SUV39H2, TST | NPSR1 2449/4885ALDH1A1 4167/4885NPC1 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.